A Study to Evaluate the Efficacy and Safety of Piracetam on Aphasia After Acute Ischemic Cerebral Artery Stroke

Clinical trial NCT01883011 · TERMINATED

Trial details

NCT number: NCT01883011
Sponsor: UCB S.A. - Pharma Sector
Status: TERMINATED
Phase: Phase 4
Study type: INTERVENTIONAL

Acute Ischaemic Middle Cerebral Artery Stroke

Start date: 1998-08-01
Primary completion: 2001-07-01
Enrollment: 571

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.